Patient
|
Sex
|
Age (yrs, median 71)
|
Sensitizing EGFR mut
|
osimertinib, response
|
plasma T790M
|
---|
Real Time PCR
|
tag-based NGS
|
---|
24
|
M
|
58
|
exon 19 del
|
PR
|
pos
|
pos
|
27
|
F
|
74
|
L858R
|
PD
|
pos
|
pos
|
25
|
F
|
71
|
L858R
|
SD
|
neg
|
pos
|
14
|
F
|
75
|
exon 19 del
|
SD
|
neg
|
nega
|
35
|
M
|
64
|
exon 19 del
|
PR
|
neg
|
pos
|
26
|
F
|
66
|
L858R
|
PR
|
neg
|
pos
|
15
|
M
|
75
|
L858R
|
SD
|
neg
|
pos
|
2
|
M
|
71
|
exon 19 del
|
PR
|
neg
|
pos
|
18
|
F
|
72
|
exon 19 del
|
PR
|
pos
|
pos
|
6
|
M
|
78
|
exon 19 del
|
PR
|
pos
|
pos
|
10
|
F
|
71
|
exon 19 del
|
PR
|
pos
|
pos
|
36
|
F
|
85
|
exon 19 del
|
SD
|
pos
|
pos
|
37
|
F
|
65
|
exon 19 del
|
PR
|
pos
|
pos
|
39
|
M
|
75
|
G719C
|
PR
|
pos
|
pos
|
33
|
F
|
82
|
L858R
|
not evaluable
|
neg
|
pos
|
16
|
F
|
66
|
exon 19 del
|
SD
|
neg
|
pos
|
22
|
F
|
62
|
exon 20 ins
|
SD
|
neg
|
pos
|
- del deletion, PR Partial Response, PD Progressive Disease, SD Stable Disease, pos positive, neg negative
- athis patient has been treated with third generation TKI because of T790M-positivity in post-TKI tissue